Gustavo Rodriguez (@JGCardio) header
Gustavo Rodriguez (@JGCardio) profile picture

Cardiólogo clínico y ecocardiografista de adultos.

Joined August 2017
Photo by Gustavo Rodriguez (@JGCardio)Photo by Gustavo Rodriguez (@JGCardio)Photo by Gustavo Rodriguez (@JGCardio)Photo by Gustavo Rodriguez (@JGCardio)Photo by Gustavo Rodriguez (@JGCardio)Photo by Gustavo Rodriguez (@JGCardio)Photo by Gustavo Rodriguez (@JGCardio)Photo by Gustavo Rodriguez (@JGCardio)Photo by Gustavo Rodriguez (@JGCardio)Photo by Gustavo Rodriguez (@JGCardio)
Gustavo Rodriguez retweeted
8 RESTING ECG ABNORMALITIES THAT MAY SIGNAL AN INCREASED RISK OF ARRHYTHMIA A resting 12-lead ECG is more than a rhythm recording. It can reveal electrical abnormalities that identify an underlying substrate for potentially serious arrhythmias. Here are eight important patterns to recognise. 1. RBBB with prolonged PR interval - Right bundle branch block with delayed AV conduction. - May indicate more extensive conduction system disease. - Assess for associated bradyarrhythmias and AV block. 2. WPW pattern - Short PR interval. - Delta wave. - Widened QRS complex. Indicates ventricular pre-excitation through an accessory pathway, with potential for AV re-entrant tachycardia and pre-excited atrial fibrillation. 3. Brugada pattern - Characteristic coved ST-segment elevation in the right precordial leads, particularly V1–V3. - Type 1 pattern is the diagnostic ECG pattern. - Associated with risk of ventricular tachycardia, ventricular fibrillation and sudden cardiac death. 4. Epsilon wave - Small signal at the end of the QRS complex, classically in V1–V3. - Associated with arrhythmogenic right ventricular cardiomyopathy (ARVC). - T-wave inversion in the right precordial leads may also occur. 5. Prolonged QT interval - Delayed ventricular repolarisation. - Predisposes to torsades de pointes and polymorphic ventricular tachycardia. 6. Short QT interval - Abnormally shortened ventricular repolarisation. - May be associated with atrial and ventricular arrhythmias. 7. Hypertrophic cardiomyopathy (HCM) - May show tall R waves and deep S waves. - Other findings include LVH voltage criteria and repolarisation abnormalities. - Certain patients are at increased risk of ventricular arrhythmias and sudden cardiac death. 8. Fragmented QRS - Additional notches or multiple deflections within the QRS complex. - May reflect myocardial scar or conduction heterogeneity. - Can be associated with ventricular arrhythmia risk. WHY DOES THIS MATTER? Recognising these patterns can help identify patients who need further evaluation. When assessing a patient with suspected arrhythmia: - Obtain and carefully interpret a 12-lead ECG. - Compare with previous ECGs. - Record a long rhythm strip to assess P waves and rhythm behaviour. - Consider electrophysiological study when clinically indicated. In selected stable patients with an unclear regular tachycardia, adenosine may help reveal atrial activity or terminate an AV node-dependent tachycardia. CLINICAL TAKEAWAY Do not look at the ECG only to identify the current rhythm. Look for the underlying electrical substrate that may explain why the patient is at risk of developing a dangerous arrhythmia.
2
23
73
3,804
Gustavo Rodriguez retweeted
🫀 CardioNugget™: congenital VSD location on echo Perimembranous vs outlet VSD can look very similar on PLAX → you often can’t reliably differentiate them there. 🔄 Go to PSAX at the aortic valve level and use the clock face: 🕙 ~10 o’clock → Perimembranous VSD 🕑 ~2 o’clock → Outlet (supracristal/subpulmonary) VSD 💡 Why it matters: Outlet VSDs are particularly associated with aortic cusp prolapse → aortic regurgitation. #CardioNugget #EchoBoards #Echocardiography #Cardiology
2
11
1
63
5,096
Gustavo Rodriguez retweeted
1/n Excited to share AI ECHO INSIGHT, the first blinded, randomized trial of AI for the full echo report, presented today by Keane Lee at #ScientificSessions26 Late-Breaking Science. EchoPrime and EchoNet-Measurements drafted the interpretations and measurements for cardiologist review. #echofirst
17
72
8
263
20,085
Preoperative medicine is not “medical clearance”: it is risk modification Surgery challenges physiological reserve. Anesthetic-induced vasodilation, blood loss, fluid shifts, inflammation and postoperative immobility can expose cardiovascular, respiratory or metabolic vulnerabilities that remain compensated in daily life. The question before surgery is not simply whether a patient is “fit,” but which risks are modifiable and which outcomes matter to the patient. In this review, Irizarry-Alvarado and colleagues challenge the ritual of preoperative clearance. They advocate a stepwise assessment anchored in symptoms, comorbid disease, medications, procedural risk and shared decision-making. More testing does not necessarily mean safer surgery. Routine laboratory panels, electrocardiography, chest radiography and ischemia testing in stable, low-risk patients can generate incidental findings, delays and downstream procedures without changing management. New exertional dyspnea, decompensated heart failure, significant valvular disease or declining exercise tolerance, by contrast, demand focused evaluation because they may signal inadequate reserve. Medication reconciliation is an intervention, not clerical work. SGLT2 inhibitors may increase perioperative ketoacidosis risk during fasting, anticoagulant interruption requires balancing bleeding against thrombosis, and GLP-1 receptor agonists prompt individualized aspiration-risk assessment. These decisions must account for the procedure and the patient rather than follow automatic rules. Importantly, frailty and baseline cognition can predict vulnerability that age alone misses. Functional decline, delirium and loss of independence may matter as much as traditional cardiopulmonary complications. Prehabilitation, nutrition, anemia management and postoperative support should enter the discussion before the operating room. This is a guideline-informed narrative review, not a trial demonstrating that any single assessment strategy improves survival. Its value is a change in clinical reasoning: avoid low-value rituals, identify actionable physiology and coordinate care. A useful preoperative consultation does not certify the absence of risk. It turns recognized risk into a plan. Reference 📚 Irizarry-Alvarado et al. 2026. JAMA Internal Medicine. doi.org/10.1001/jamainternme… #PerioperativeMedicine #Anesthesiology #PatientSafety #ClinicalReasoning #EvidenceBasedMedicine
2
79
1
218
10,543
🫀 Tricuspid regurgitation is no longer the “forgotten” valve—but when is the right time to intervene? A review of the 2025 ESC/EACTS update explores imaging, patient selection, and surgical and transcatheter treatment options. 🔗 imrpress.com/journal/RCM/27/… #TricuspidRegurgitation #Cardiology #StructuralHeart
1
10
3
50
2,785
Gustavo Rodriguez retweeted
Bioprosthetic valve dysfunction (BVD), hemodynamic valve dysfunction (HVD), and bioprosthetic valve failure (BVF): they may sound synonymous, but they are not. I tried to clarify the differences. The discussion also brought back the valve durability clock, which divided the panel. Some argued that it is not a major concern: we intervene earlier because intervention will eventually be necessary anyway. I somewhat disagree. To me, this is a conceptual and, to some extent, an ethical issue, particularly since we are not talking about a demonstrated mortality benefit of early intervention over clinical surveillance. Symptoms will eventually develop, but how soon? Moderate stenosis will eventually progress to severe stenosis, but over what timeframe? Intervening 1–2 years earlier in a patient whose life expectancy is shorter than the valve’s remaining durability is one thing. Intervening 5–6 years earlier in a patient who is likely to outlive the valve is quite another. In the latter scenario, I believe we should seriously question whether early intervention is preferable to clinical surveillance. Perhaps it is time to revisit the natural history studies of aortic stenosis, which certainly exist, to better understand the time course of progression from, e.g., moderate to severe stenosis, and from an asymptomatic state to the development of symptoms. #TCT2026
2
24
89
6,804
🫀 New review on tricuspid regurgitation! 🔹Phenotype & RV–PA coupling 🔹Patient selection & timing 🔹Residual TR matters 👏 Congrats to Javier Solsona, @iLauraGG & our Vall d’Hebron team! 📖 Read the paper: mdpi.com/2077-0383/15/21/858… @vallhebron @VHIR_ @cardioimagenVH
41
121
6,139
Gustavo Rodriguez retweeted
Deprescripción cardiovascular en el paciente mayor frágil: qué retirar, en qué orden y qué no tocar sin cardiología La píldora reúne lo que dicen la guía ESC 2024 de hipertensión, los criterios STOPP/START versión 3 y el estudio OPTIMISE sobre la retirada de fármacos cardiovasculares en el paciente mayor frágil. Incluye una tabla fármaco por fármaco, el orden de la retirada y los tratamientos que no se suspenden sin consultar con cardiología. cardioteca.com/cardiologia-c… 🩺 La guía ESC 2024 de hipertensión pide cribar la fragilidad con pruebas validadas y admite retirar antihipertensivos cuando la presión baja al avanzar la fragilidad. 📉 En el estudio OPTIMISE, con 569 pacientes de 80 años o más, retirar un antihipertensivo mantuvo la presión sistólica por debajo de 150 mmHg en el 86% frente al 88% con el tratamiento habitual. 💊 Los criterios STOPP/START versión 3 señalan el ácido acetilsalicílico en prevención primaria y la estatina en prevención primaria a partir de los 85 años con fragilidad establecida y esperanza de vida menor de 3 años. 🫀 La antiagregación tras un stent reciente, el tratamiento de la insuficiencia cardiaca con FEVI reducida y la anticoagulación con una prótesis mecánica no se retiran sin hablarlo con cardiología.
27
1
70
3,870
🫀 Can coronary atherosclerosis actually regress? Our new randomized FLOWPROMOTE trial analysis, published TODAY in JAMA Cardiology, shows remarkable coronary plaque regression with intensive LDL-C lowering! Atherosclerosis is not necessarily a one-way process. 📄 JAMA Cardiology: doi.org/10.1001/jamacardio.2… #Atherosclerosis #LDL #Cardiology #CCTA
79
382
59
1,392
264,263
Gustavo Rodriguez retweeted
Cómo ajustar la dosis de acenocumarol y warfarina según el INR: tabla, reparto semanal y vitamina K La píldora explica cómo modificar la dosis total semanal de acenocumarol y warfarina según el INR, cómo repartirla en comprimidos y cuándo repetir el control. Recoge la tabla de ajuste de la CAMFiC, las pautas de vitamina K de la ficha técnica y cuatro casos resueltos. cardioteca.com/cardiologia-c… 📊 El ajuste se hace sobre la dosis total semanal: en la tabla de la CAMFiC, un 10% con INR de 1,5 a 1,7 o de 3,3 a 4,9 y un 20% con INR menor de 1,5. ⚖️ Con un INR aislado a 0,5 o menos del rango en un paciente estable, la guía ACCP sugiere mantener la dosis y repetir el control en 1 a 2 semanas. 💊 Con acenocumarol e INR de 4,5 a 10 sin sangrado, la ficha técnica indica interrumpir el tratamiento sin vitamina K; por encima de 10, de 1 a 5 mg por vía oral. 🔁 Con un tiempo en rango inferior al 70%, la guía ESC 2024 recomienda pasar a un anticoagulante oral directo si no hay contraindicación.
42
1
124
7,506
Gustavo Rodriguez retweeted
Updated intro2echo.com with sections on structural heart echo. Walks through the steps for TAVR, mTEER, and tTEER. This includes 3D models as well as simulated 2D ultrasound images. Would appreciate feedback and suggestions for improvement! intro2echo.com/#mteer
6
50
3
258
17,280
Gustavo Rodriguez retweeted
🫀From Healthy Atria to Atrial Failure: Rethinking Atrial Cardiomyopathy (AtCM) from the #HFA_ESC clinical consensus statement: 📍AtCM extends beyond #AF: Electrical, mechanical & structural abnormalities may precede clinically apparent AF or #HeartFailure 📍Diagnosis: Electrical atrial dysfunction (P-wave score ≥1) PLUS ≥1 of: mechanical dysfunction, atrial enlargement or excessive atrial fibrosis 📍Proposed diagnostic thresholds: - P-wave ≥120 ms (standard ECG) or ≥150 ms (amplified ECG) - Advanced interatrial block: P-wave ≥120 ms + biphasic morphology in ≥2 inferior leads - LA reservoir strain <23% - LAVi >40 mL/m² (>48 mL/m² in women >65 years) - Atrial fibrosis: thresholds pending validation 📍New P-wave scoring system (0–4): Ranges from normal P-wave (0), prolonged P-wave (1), advanced interatrial block without (2) or with paroxysmal arrhythmia (3), to persistent atrial arrhythmia (4). 📍Atrial failure: End-stage AtCM, characterized by persistent AF or HF with symptoms attributable to atrial disease. 📍Early recognition matters! Risk factor & comorbidity management may help prevent or delay progression to atrial failure. Read more in #EJHF @EJHFEiC 🔗 doi.org/10.1002/ejhf.3782 @escardio @h_arfsten @GTersalvi @jozinetm
69
1
178
12,913
Gustavo Rodriguez retweeted
A defining study on evaluating MR with Echocardiography & impact on @ASE360 Guidelines. @ACCinTouch @SCMRorg
🎯 Less is more in mitral regurgitation assessment In 177 patients undergoing near-simultaneous Echo & CMR, just 2 ASE criteria identified significant MR with 91–95% specificity. 🫀 Smarter integration, less quantification, greater diagnostic confidence doi.org/10.1016/j.jcmg.2026.…
1
19
63
5,131
Gustavo Rodriguez retweeted
Sharing here the #LAAO #LAAC simulator laa.liorjankelson.com. See the left atrial appendage with 3D CT correlation, explore LAAOD positioning, play with device alignment, see "shoulders" and leaks in each view and more. #eppeeps #afib
2
43
1
224
11,882
Gustavo Rodriguez retweeted
ECG patterns suggestive of left main disease. Pay close attention to lead aVR.
39
174
8,081
Gustavo Rodriguez retweeted
🫀 Are we measuring pericardial effusions the wrong way? We routinely classify pericardial effusions as small, moderate, or large based on linear measurements. But does a single measurement in millimeters accurately represent the actual volume of pericardial fluid? Study in @JournalASEcho challenges this onlinejase.com/article/S0894… 🔬 245 patients undergoing pericardiocentesis Median drained volume: 500 mL (range 50–4,300 mL) 76.7% had cardiac tamponade Actual drained volume served as the reference standard. 📊 How did different echo methods perform? Between end diastolic thickness, plax and PSAx area- apical 4 chamber Simpson’s volumetric estimation performed the best ✅ Accuracy: 80.4% vs 49.4% Perhaps it is time to rethink how we quantify pericardial effusions! 💡 if volumetric assessment is substantially more accurate, should we move from millimeters to milliliters in routine echocardiography? And more importantly, would this change clinical decision-making—or simply improve the precision of our reports? #EchoFirst #CardioTwitter #CVImaging
4
63
1
175
10,692
Gustavo Rodriguez retweeted
Guarda esta imagen, luego me agradeces. Si un paciente con FA presenta un ACVi mientras recibe anticoagulación, el riesgo de transformación hemorrágica obliga a suspenderla. La pregunta de siempre es: ¿cuándo reiniciarla? Esta gráfica ayuda a responderlo y, en general, favorece el reinicio durante la primera semana especialmente si no existe transformación hemorrágica o no es extensa la isquemia.
5
132
2
408
17,002
Gustavo Rodriguez retweeted
🧵 PREECLAMPSIA 2026 | Lo que ha cambiado y debes recordar La última revisión de The Lancet actualiza diagnóstico, prevención y tratamiento. Varias ideas clásicas han quedado atrás 👇
1
128
384
10,761
Gustavo Rodriguez retweeted
🥁Trabajo imperdible y necesario¡¡¡ bit.ly/4nxvMU8 🚩Nuevo algoritmo para estimar las presiónes de llenado con Ecocardio: ➡️Reduce significativamente los casos indeterminados. ➡️Mejora la precisión para identificar presión de llenado elevada, especialmente en pacientes con FEVI normal. ➡️Combinado con péptidos natriuréticos, mejora la identificación de insuficiencia cardíaca.
59
201
12,288
Gustavo Rodriguez retweeted
Nuevo consenso sobre la Hipertensión Resistente Integra al abordaje el acrónimo RESIST para el diagnóstico, manejo y envío con especialistas Am Coll Cardiol 2026 10.1016/j.jacc.2026.08.028
1
139
410
13,275